COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,046 Articles (22,627 medRxiv, 8,419 bioRxiv)

Most recent first Previous |  Page 1139: Articles 11381-11390  | Next

The Persistence of Neutralising Antibodies up to 11 months after SARS-CoV-2 Infection in the Southern Region of New Zealand
McGregor, R., Craigie, A. K., Jack, S., Upton, A., Moreland, N. J., Ussher, J.
10.1101/2021.10.26.21265501 — Posted: 2021-10-27
Dampening of the respiratory cytokine storm is promoted by inhaled budesonide in patients with early COVID-19
Baker, J. R., Mahdi, M., Nicolau, D. V., Ramakrishnan, S., Barnes, P. J., Simpson, J. L., Cass, S., Russell, R. E. K., Donnelly, L. E., Bafadhel, M.
10.1101/2021.10.26.21265512 — Posted: 2021-10-27
Mobility network reveals the impact of geographic vaccination heterogeneity on COVID-19
Yuan, Y., Jahani, E., Zhao, S., Ahn, Y.-Y., Pentland, A. S.
10.1101/2021.10.26.21265488 — Posted: 2021-10-27
Boosting of the SARS-CoV-2-specific immune response after vaccination with single-dose Sputnik Light vaccine
Komissarov, A., Dolzhikova, I., Efimov, G., Logunov, D., Mityaeva, O., Molodtsov, I., Naigovzina, N., Peshkova, I., Shcheblyakov, D., Volchkov, P., Vasilieva, E.
10.1101/2021.10.26.21265531 — Posted: 2021-10-27
Kinetics of immune responses to the AZD1222/Covishield vaccine with varying dose intervals in Sri Lankan individuals
Jeewandara, C., Aberathna, I., Gomes, L., Pushpakumara, P., Danasekara, S., Guruge, D., Ranasinghe, T., Gunasekara, B., Kamaladasa, A., Kuruppu, H., Somathilaka, G., Dissanayaka, O., Gamalath, N., Ekanayaka, D., Jayamali, J., Jayathilaka, D., Mudunkotuwa, A., Harvie, M., Nimasha, T., Wijayamuni, R., Schimanski, L., Rijal, P., Tan, T., Tong, T., Townsend, A., Ogg, G., Malavige, G. N.
10.1101/2021.10.27.21265561 — Posted: 2021-10-27
Deep autoencoder enables interpretable tissue-adaptive deconvolution and cell-type-specific gene analysis
Chen, Y., Wang, Y., Chen, Y., Wei, Y., Li, Y., Chan, T.-F., Li, Y.
10.1101/2021.10.26.465846 — Posted: 2021-10-27
Integrated Genomic Surveillance reveals extensive onward transmission of travel-imported SARS-CoV-2 infections in the community
Houwaart, T., Belhaj, S., Tawalbeh, E., Nagels, D., Finzer, P., Stiller, L., Blum, J., Lange, C., Fröhlich, Y., Benmoumene, A., Asskali, D., Haidar, H., von Dahlen, J., Adelmann, C., Schroer, B., Osmers, U., Grice, C., Kirfel, P. P., Jomaa, H., Pigulla, M., Kreuzer, P., Tyshaieva, A., Weber, J., Strelow, D., Nicolai, J., Wienemann, T., Kohns Vasconcelos, M., Hülse, L., Hoffmann, K., Lübke, N., Hauka, S., Andree, M., Scholz, C. J., Jazmati, N., Göbels, K., Zotz, R., Pfeffer, K., Timm, J., Ehlkes, L., Walker, A., Dilthey, A. T., German COVID-19 OMICS Initiative (DeCOI)
10.1101/2021.10.18.21264530 — Posted: 2021-10-26
Excessive inflammatory and metabolic responses to acute SARS-CoV-2 infection are associated with a distinct gut microbiota composition
Albrich, W. C., Ghosh, T. S., Ahearn-Ford, S., Mikaeloff, F., Lunjani, N., Forde, B., Suh, N., Kleger, G.-R., Pietsch, U., Frischknecht, M., Garzoni, C., Forlenza, R., Horgan, M., Sadlier, C., Negro, T. R., Pugin, J., Wozniak, H., Cerny, A., Neogi, U., O'Toole, P. W., O'Mahony, L.
10.1101/2021.10.26.465865 — Posted: 2021-10-26
Trends in social exposure to SARS-Cov-2 in France. Evidence from the national socio-epidemiological cohort - EPICOV
WARSZAWSKI, J., Meyer, L., Franck, J.-E., Rahib, D., Lydie, N., Gosselin, A., Counil, E., Kreling, R., Novelli, S., Slama, R., Raynaud, P., Bagein, G., Costemalle, V., Sillard, P., Fourie, T., de Lamballerie, X., Bajos, N., EpiCov Study Group
10.1101/2021.10.25.21265456 — Posted: 2021-10-26
A "Made-in-Canada" serology solution for profiling humoral immune responses to SARS-CoV-2 infection and vaccination
Colwill, K., Galipeau, Y., Stuible, M., Gervais, C., Arnold, C., Rathod, B., Abe, K. T., Wang, J. H., Pasculescu, A., Maltseva, M., Rocheleau, L., Pelchat, M., Fazel-Zarandi, M., Iskilova, M., Barrios-Rodiles, M., Bennett, L., Yau, K., Cholette, F., Mesa, C., Li, A. X., Paterson, A., Hladunewich, M. A., Goodwin, P. J., Wrana, J. L., Drews, S. J., Mubareka, S., McGeer, A. J., Kim, J., Langlois, M.-A., Gingras, A.-C., Durocher, Y.
10.1101/2021.10.25.21265476 — Posted: 2021-10-26

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).